Comparing Effectiveness of Colonoscopy versus Fecal Immunochemical Testing in Screening for Colorectal Cancer
Creative Commons License
This work is licensed under a Creative Commons Attribution-Noncommercial-No Derivative Works 4.0 License.
Date of Graduation
Introduction: Colorectal cancer (CRC) is deadly neoplasm that takes many lives in the United States and is a leading cause of cancer worldwide. If CRC is detected early through screening, there is a higher chance of remission which makes screening an important tool in CRC prevention. Currently, colonoscopy is the gold standard, but due to the undesirable preparation needed for a colonoscopy, patient compliance is low. Giving patients a screening option that requires less preparation may help to increase the compliance for CRC screening. Fecal Immunological testing has been shown to have higher compliance rates among patients as compared to colonoscopy.
Objective: The purpose of this paper is to evaluate three research studies to compare the effectiveness of FIT to the gold standard colonoscopy.
Methods: Utilized PubMed database with several MeSH terms: colorectal neoplasms, diagnosis, and colonoscopy to find the three articles outlined in this paper.
Results: All three studies demonstrated that FIT had comparable effectiveness in detecting colorectal cancer but was insufficient in detecting advanced adenomas in comparison to colonoscopy. A high compliance rate was noted among the FIT group versus colonoscopy, as well.
Conclusions: We recommend that colonoscopy remain the gold standard to be conducted every 10 years with a yearly FIT to attempt to detect rapidly growing neoplasms. Further research should be conducted in which all participants complete a FIT and undergo a colonoscopy.
Burns L., VanRooyen H., Comparing Effectiveness of Colonoscopy versus Fecal Immunochemical Testing in Screening for Colorectal Cancer. JMU Scholarly Commons Physician Assistant Capstones. https://commons.lib.jmu.edu/pacapstones/ Published December 11, 2019.